Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study | Journal of Negative Results in BioMedicine BioMed Central Research Evaluation of vardenafil for the treatment of subjective tinnitus a controlled pilot study Birgit Mazurek 1 Heidemarie Haupt1 Agnieszka J Szczepek1 Jorg Sandmann1 Johann Gross1 Burghard F Klapp2 Holger Kiesewetter3 Ulrich Kalus3 Timo Stover4 and Philipp P Caffier1 Address Department of Otorhinolaryngology Tinnitus Centre and Molecular Biology Research Laboratory Charité - Universitatsmedizin Berlin Chariteplatz 1 10117 Berlin Germany 2Department of Internal Medicine Division Psychosomatics and Psychotherapy Charité -Universitatsmedizin Berlin Chariteplatz 1 10117 Berlin Germany institute for Transfusion Medicine Charité - Univeritatsmedizin Berlin Chariteplatz 1 10117 Berlin Germany and 4Department of Otorhinolaryngology Medical University of Hannover Carl-Neuberg-Strasse 1 30625 Hannover Germany Email Birgit Mazurek - birgit.mazurek@charite.de Heidemarie Haupt-heidemarie.haupt@charite.de Agnieszka J Szczepek - agnes.szczepek@charite.de Jorg Sandmann - joerg.sandmann@charite.de Johann Gross - johann.gross@charite.de Burghard F Klapp - burghard.klapp@charite.de Holger Kiesewetter - holger.kiesewetter@charite.de Ulrich Kalus - ulrich.kalus@charite.de Timo Stover - stoever.timo@mh-hannover.de Philipp P Caffier - philipp.caffier@charite.de Corresponding author Open Access Published 17 February 2009 Received 9 December 2008 Journal of Negative Results in BioMedicine 2009 8 3 doi l0.ll86 l 477-5751-8-3 Accepted I7 February 2009 This article is available from http www.jnrbm.cOm content 8 1 3 2009 Mazurek et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Vardenafil Levitra represents a potent and highly selective phosphodiesterase type 5 PDE5
